BLASCHKE B, WEBER RG, LICHTER P, ICHIMURA K, COLLINS VP, REIFENBERGER G (2001) Alterations of the tumor suppressor genes CDKN2A ( p16INK4a ), p14ARF , CDKN2B ( p15INK4b ), and CDKN2C ( p18INK4c ) in atypical and [...] Clin Neuropathol. 2016 Jan-Feb;35(1):3-12. WICK W, WIESTLER B, ROTH P, HARTMANN C, HAU P, NAKAMURA M, STOCKHAMMER F, SABEL MC, WICK A, KOEPPEN S, KETTER R, VAJKOCZY P, EYUPOGLU I, KALFF, R, HAPPOLD C, [...] HARTMANN C, KICKINGEREDER P, COLLINS P, PFISTER S, VON DEIMLING A. AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry. Acta

model. Pathog Dis 2015; 73: 1-8. Kashani E, Fohse L, Raha S, Sandrock I, Oberdorfer L, Koenecke C, Suerbaum S, Weiss S, Prinz I. A clonotypic Vgamma4Jgamma1/Vdelta5Ddelta2Jdelta1 innate gammadelta T-cell [...] anaphylotoxin receptors C5aR1 and C5aR2 to the early innate immune response against Staphylococcus aureus infection. Pathogens 2015; 4: 722-738. Janik K, Bode J, Dutow P, Laudeley R, Geffers R, Sommer [...] RP, Gastmeier P. Primary and secondary literature should be distinguished when searching for data used in systematic reviews of nosocomial outbreaks. Infect Control Hosp Epidemiol 2015; 1-2. von Lengerke

Eggers H, Wegener G, Kuczyk MA, Kreipe HH, Grünwald V, Schrader AJ, Ivanyi P: Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma? Med Oncol [...] Sinn P, Gerharz CD, Koch W, Morris S, Ammann J, Untch M; Nicht-interventionelle Untersuchung (NIU) HER2 Study Group.. Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity [...] Großhennig A, Becker JU, Wegener G, Schrader AJ, Grünwald V, Ivanyi P: Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC). Med Oncol

2004; 28: 1081-3 Langner C, von Wasielewski R, Ratschek M, Rehak P, Zigeuner R: Expression of p27 and its ubiquitin ligase subunit SKP2 in upper urinary tract transitional cell carcinoma. Urology 2004; [...] 2004; (im Druck) Langner C, von Wasielewski R, Ratschek M, Rehak P, Zigeuner R: Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour [...] Flemming P, Lochs H, Haverich A, Schmidt HH: LMNA Mutations in Cardiac Transplant Recipients. Cardiology 2004; 103(2): 57-62; [Epub ahead of print] Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka

MJ, Nakazato M, Flemming P, Kubicka S, Boker K, Pichlmayr R, Manns MP: Familial Amyloidotic Polyneuropathy: domino liver transplantation. J Hepatol 1999; 30(2): 293-8 Schöffski P, Tacke F, Weihkopf T, H [...] 345-50 Trautwein C, Will M, Kubicka S, Rakemann T, Flemming P, Manns MP: 2-acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of cyclin E expression. Oncogene 1999; [...] of G1 cell cycle control proteins. J Gen Virol 1999; 80(7): 1599-1608 Fieguth A, Kuske M, Debertin AS: Death caused by neglect? Arch Kriminol 1999; 204(5-6): 156-62 Fuchs J, Wunsch L, Flemming P, Weinel

Veröffentlichungen 2009 Ahrens P, Kreipe H: [BRCA1- and BRCA2- associated breast carcinomas.] Pathologe 2009; Suppl. 2: 207-209 [German] Athanassiadi K, Laenger F, Dickgreber N, Haverich A: Multiple i [...] disease with concurrent MPLW515L/JAK2V617F mutation. Blood 2009; 113(6): 1391-2 Hussein K, Bock O, Theophile K, von Neuhoff N, Buhr T, Schlué J, Büsche G, Kreipe H: JAK2(V617F) allele burden discriminates [...] ation 2009; 87(10): 1468-77 Kümpers P, David S, Haubitz M, Hellpap J, Horn R, Bröcker V, Schiffer M, Haller H, Witte T: The Tie2 receptor antagonist angiopoietin 2 faciliates vascular inflammation in systemic

mechanism. (2017) Sci. Rep. 7 (1):4160. Lohöfener J, Steinke N, Kay-Fedorov P, Baruch P, Nikulin A, Tishchenko S, Manstein DJ, and Fedorov R. The activation mechanism of 2’-5’-oligoadenylate synthetase [...] (2006) J. Chem. Theory Comput. ; 2 (6), 1565 – 1574. Matter HH, Arun Kumar HS, Fedorov R, Frey A, Kotsonis P, Hartmann E, Fröhlich LG, Reif A, Pfleiderer W, Scheurer P, Ghosh DK, Schlichting I and Schmidt [...] of Archaeal Ribosomal Protein L4. (2014) Biochemistry (Moscow) . 79 (1):69-76. Führing J, Cramer JT, Routier FH, Lamerz A-C, Baruch P, Gerardy-Schahn R and Fedorov R. Catalytic mechanism and allosteric

down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression". J Transl Med 2010; 8:33 Müller-Deile J, Bröcker V , Grünwald [...] 2010;31 Suppl. 2: 116-8 [German] Kreipe HH, Ahrens P, Christgen M, Lehmann U, Länger F : [Beyond staging, typing and grading. New challenges in breast cancer pathology] Pathologe 2010; 31(1): 54-9 [Review [...] West C, Williams K, Brabant G: Expression of hypoxia inducible factor 1 {alpha} in thyroid carcinomas. Endocr Relat Cancer 2010; 17(1): 61-72 Capelle HH, Brandis A , Tschan CA, Krauss JK: Treatment of recurrent

https://orcid.org/0000-0002-7280-5663 ): Oelschlegel AM, Bhattacharjee R, Wenk P, Harit K, Rothkötter HJ, Koch SP, Boehm-Sturm P, Matuschewski K, Budinger E, Schlüter D, Goldschmidt J, Nishanth G ( 2024) Beyond [...] experimental cerebral malaria. Nat Commun. 15(1):2396. doi: 10.1038/s41467-024-46617-w. Haage TR, Charakopoulos E, Bhuria V, Baldauf CK, Korthals M, Handschuh J, Müller P, Li J, Harit K, Nishanth G , Frey S, Böttcher [...] J (2024) Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia. Hematol Oncol. 17(1):43. doi: 10.1186/s13045-024-01562-5. Zhuang

M , Lortz S , Mehmeti I (2023). Luminal H2 O2 promotes ER Ca2+ dysregulation and toxicity of palmitate in insulin-secreting INS-1E cells. FASEB J. 2023 Jan;37(1):e22685. doi: 10.1096/fj.202201237R. PMID: [...] (14):4337-4344. Drake, P.M. , Nathan. J.K., Stock, C.M., Chang, P.V., Muench, M.O., Nakata, D., Reader, J.R., Gip, P., Golden, K.P., Weinhold, B. , Gerardy-Schahn, R. , Troy, F.A. 2nd, and Bertozzi, C.R [...] Bihl F, Zaghrini C, Justino J, Payré C, Mansuelle P, Garbers C, Ronco P, Checler F, Lambeau G, Petit-Paitel A (2024). Ectodomain shedding of PLA2R1 is mediated by the metalloproteases ADAM10 and ADAM17